Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patients

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  De Pergola, Giovanni ^a   Nitti, Alessandro ^a   Bartolomeo, Nicola ^a   Gesuita, Antonella ^a   Giagulli, Vito Angelo ^b   Triggiani, Vincenzo ^a   Guastamacchia, Edoardo ^a   Silvestris, Franco ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b ASL Bari   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; HORMONE; LIPID; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; ADOLESCENT; ANTHROPOMETRY; BLOOD; COHORT ANALYSIS; HYPERINSULINISM; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; ANTHROPOMETRY; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HORMONES; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; VITAMIN D; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84874626089     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/921348     Document Type: Article

References (44)

1. Holick M. F., Medical progress: vitamin D deficiency. The New England Journal of Medicine 2007 357 3 266 281 2-s2.0-34447514029 10.1056/NEJMra070553 (Pubitemid 47080391)
2. Dawson-Hughes B., Serum 25-hydroxyvitamin D and functional outcomes in the elderly. American Journal of Clinical Nutrition 2008 88 2 S537 S540 2-s2.0-49449097261
3. van Schoor N. M., Visser M., Pluijm S. M. F., Kuchuk N., Smit J. H., Lips P., Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 2008 42 2 260 266 2-s2.0-37849006465 10.1016/j.bone.2007.11.002
4. Nagpal S., Na S., Rathnachalam R., Noncalcemic actions of vitamin D receptor ligands. Endocrine Reviews 2005 26 5 662 687 2-s2.0-23744437421 10.1210/er.2004-0002 (Pubitemid 41127276)
5. Rosen C. J., Vitamin D insufficiency. The New England Journal of Medicine 2011 364 3 248 254 2-s2.0-79952148734 10.1056/NEJMcp1009570
6. Parikh S. J., Edelman M., Uwaifo G. I., Freedman R. J., Semega-Janneh M., Reynolds J., Yanovski J. A., The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. Journal of Clinical Endocrinology and Metabolism 2004 89 3 1196 1199 2-s2.0-1642317096 10.1210/jc.2003-031398 (Pubitemid 38368412)
7. Cheng S., Massaro J. M., Fox C. S., Larson M. G., Keyes M. J., McCabe E. L., Robins S. J., O'Donnell C. J., Hoffmann U., Jacques P. F., Booth S. L., Vasan R. S., Wolf M., Wang T. J., Adiposity, cardiometabolic risk, and vitamin D status: the framingham heart study. Diabetes 2010 59 1 242 248 2-s2.0-77449105166 10.2337/db09-1011
8. Need A. G., O'Loughlin P. D., Horowitz M., Nordin B. E. C., Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clinical Endocrinology 2005 62 6 738 741 2-s2.0-20444441550 10.1111/j.1365-2265.2005.02288.x (Pubitemid 40825945)
9. Konradsen S., Ag H., Lindberg F., Hexeberg S., Jorde R., Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. European Journal of Nutrition 2008 47 2 87 91 2-s2.0-43449088503 10.1007/s00394-008-0700- 4
10. Liu E., Meigs J. B., Pittas A. G., Economos C. D., McKeown N. M., Booth S. L., Jacques P. F., Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. American Journal of Clinical Nutrition 2010 91 6 1627 1633 2-s2.0-77953051485 10.3945/ajcn.2009.28441
11. Scragg R., Sowers M., Bell C., Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004 27 12 2813 2818 2-s2.0-9444229305 10.2337/diacare.27.12.2813 (Pubitemid 39565042)
12. Lu L., Yu Z., Pan A., Hu F. B., Franco O. H., Li H., Li X., Yang X., Chen Y., Lin X., Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009 32 7 1278 1283 2-s2.0-67650066856 10.2337/dc09-0209
13. Zhao G., Ford E. S., Li C., Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care 2010 33 2 344 347 2-s2.0-75149152979 10.2337/dc09-0924
14. Liu E., Meigs J. B., Pittas A. G., McKeown N. M., Economos C. D., Booth S. L., Jacques P. F., Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. Journal of Nutrition 2009 139 2 329 334 2-s2.0-60249087200 10.3945/jn.108.093831
15. Chiu K. C., Chu A., Go V. L. W., Saad M. F., Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. American Journal of Clinical Nutrition 2004 79 5 820 825 2-s2.0-2442526414 (Pubitemid 41103882)
16. Jablonski K. L., Chonchol M., Pierce G. L., Walker A. E., Seals D. R., 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011 57 1 63 69 2-s2.0-78650849973 10.1161/HYPERTENSIONAHA.110.160929
17. Peterson C. A., Heffernan M. E., Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. Journal of Inflammation 2008 5 article no. 10 2-s2.0-49249085519 10.1186/1476-9255-5-10
18. Ngo D. T., Sverdlov A. L., McNeil J. J., Horowitz J. D., Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? American Journal of Medicine 2010 123 4 335 341 2-s2.0-77950240732 10.1016/j.amjmed.2009.09.024
19. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., Kinkeldei J., Boehm B. O., Weihrauch G., Maerz W., Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Archives of Internal Medicine 2008 168 12 1340 1349 2-s2.0-46449131684 10.1001/archinte.168.12.1340 (Pubitemid 351930842)
20. Bellia A., Garcovich C., D'Adamo M., Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Internal and Emergency Medicine. In press 10.1007/s11739-011-0559-x
21. Hyppönen E., Berry D., Cortina-Borja M., Power C., 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PloS one 2010 5 5 e10801 2-s2.0-77956287506 10.1371/journal.pone.0010801
22. Peterson C. A., Heffernan M. E., Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. Journal of Inflammation 2008 5 article no. 10 2-s2.0-49249085519 10.1186/1476-9255-5-10
23. Vilarrasa N., Vendrell J., Maravall J., Elío I., Solano E., San José P., García I., Virgili N., Soler J., Gómez J. M., Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 2010 38 2 235 242 2-s2.0-78149407895 10.1007/s12020-010-9379-4
24. Zittermann A., Frisch S., Berthold H. K., Götting C., Kuhn J., Kleesiek K., Stehle P., Koertke H., Koerfer R., Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. American Journal of Clinical Nutrition 2009 89 5 1321 1327 2-s2.0-65549137566 10.3945/ajcn.2008.27004
25. Amer M., Qayyum R., Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). American Journal of Cardiology 2012 109 226 230 10.1016/j.amjcard.2011.08.032
26. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D. R., Miles J. M., Yudkin J. S., Klein S., Coppack S. W., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor- α in vivo. Journal of Clinical Endocrinology and Metabolism 1997 82 12 4196 4200 2-s2.0-0030735542 (Pubitemid 27525539)
27. Gabrielsson B. G., Johansson J. M., Lönn M., Jernås M., Olbers T., Peltonen M., Larsson I., Lönn L., Sjöström L., Carlsson B., Carlsson L. M. S., High expression of complement components in omental adipose tissue in obese men. Obesity Research 2003 11 6 699 708 2-s2.0-2942564894 (Pubitemid 41151596)
28. Koistinen H. A., Vidal H., Karonen S. L., Dusserre E., Vallier P., Koivisto V. A., Ebeling P., Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 6 1034 1039 2-s2.0-0035715733 (Pubitemid 34168665)
29. Muscari A., Massarelli G., Bastagli L., Poggiopollini G., Tomassetti V., Drago G., Martignani C., Pacilli P., Boni P., Puddu P., Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. European Heart Journal 2000 21 13 1081 1090 2-s2.0-0034094983 10.1053/euhj.1999.2013 (Pubitemid 30352992)
30. Muscari A., Antonelli S., Bianchi G., Cavrini G., Dapporto S., Ligabue A., Ludovico C., Magalotti D., Poggiopollini G., Zoli M., Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: Comparison study in an elderly population. Diabetes Care 2007 30 9 2362 2368 2-s2.0-34548398561 10.2337/dc07-0637 (Pubitemid 47359047)
31. De Pergola G., Ciccone M. M., Guida P., Morea G., Giannuzzo E., Cortese F., Scicchitano P., Favale S., Silvestris F., Relationship between C3 levels and common carotid intima-media thickness in overweight and obese patients. Obesity Facts 2011 4 2 159 163 2-s2.0-79956066813 10.1159/000327893
32. Pearson T. A., Mensah G. A., Alexander R. W., Anderson J. L., Cannon R. O., Criqui M., Fadl Y. Y., Fortmann S. P., Hong Y., Myers G. L., Rifai N., Smith S. C., Taubert K., Tracy R. P., Vinicor F., Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003 107 3 499 511 2-s2.0-0037469232 10.1161/01.CIR.0000052939.59093.45 (Pubitemid 36158056)
33. Bonora E., Targher G., Alberiche M., Bonadonna R. C., Saggiani F., Zenere M. B., Monauni T., Muggeo M., Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000 23 1 57 63 2-s2.0-0033961701 (Pubitemid 30022895)
34. Wortsman J., Matsuoka L. Y., Chen T. C., Lu Z., Holick M. F., Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition 2000 72 3 690 693 2-s2.0-0033847865 (Pubitemid 30667088)
35. Tzotzas T., Papadopoulou F. G., Tziomalos K., Karras S., Gastaris K., Perros P., Krassas G. E., Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. Journal of Clinical Endocrinology and Metabolism 2010 95 9 4251 4257 2-s2.0-77956606549 10.1210/jc.2010-0757
36. Shahar D. R., Schwarzfuchs D., Fraser D., Vardi H., Thiery J., Fiedler G. M., Blüher M., Stumvoll M., Stampfer M. J., Shai I., Dairy calcium intake, serum vitamin D, and successful weight loss. American Journal of Clinical Nutrition 2010 92 5 1017 1022 2-s2.0-78149264597 10.3945/ajcn.2010.29355
37. Ding C., Parameswaran V., Blizzard L., Burgess J., Jones G., Not a simple fat-soluble vitamin: changes in serum 25-(OH)D levels are predicted by adiposity and adipocytokines in older adults. Journal of Internal Medicine 2010 268 5 501 510 2-s2.0-77958523146 10.1111/j.1365-2796.2010.02267.x
38. De Pergola G., Ammirati A., Caccavo D., Bavaro S., Barone G., Vitamin D, obesity and risk of diabetes. Nutritional Therapy and Metabolism 2012 30 2 59 66
39. Boucher B. J., Mannan N., Noonan K., Hales C. N., Evans S. J. W., Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 1995 38 10 1239 1245 2-s2.0-0029152846 10.1007/s001250050418
40. Kayaniyil S., Vieth R., Retnakaran R., Knight J. A., Qi Y., Gerstein H. C., Perkins B. A., Harris S. B., Zinman B., Hanley A. J., Association of vitamin D with insulin resistance and β -cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010 33 6 1379 1381 2-s2.0-77955468245 10.2337/dc09-2321
41. Borissova A. M., Tankova T., Kirilov G., Dakovska L., Kovacheva R., The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. International Journal of Clinical Practice 2003 57 4 258 261 2-s2.0-0037527609 (Pubitemid 36700706)
42. Nagpal J., Pande J. N., Bhartia A., A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabetic Medicine 2009 26 1 19 27 2-s2.0-58149216055 10.1111/j.1464-5491.2008. 02636.x
43. Von Hurst P. R., Stonehouse W., Coad J., Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. British Journal of Nutrition 2010 103 4 549 555 2-s2.0-77649219884 10.1017/S0007114509992017
44. Maestro B., Campión J., Dávila N., Calle C., Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocrine Journal 2000 47 4 383 391 2-s2.0-0033823521